Business

Invaio Sciences Strengthens Leadership Team with Appointment of Peleg Chevion as President and Chief Commercial Officer

CAMBRIDGE, Mass., March 30, 2021 /PRNewswire/ -- Invaio Sciences, Inc., a Flagship Pioneering company focused on unlocking the potential of the planet's

articleDenali Therapeutics Inc.March 30, 20213/company/denali-therapeutics-inc/news/invaio-sciences-strengthens-leadership-team-with-appointment-of-peleg-chevion-as
Invaio Sciences Strengthens Leadership Team with Appointment of Peleg Chevion as President and Chief Commercial Officer

About this update from Denali Therapeutics Inc.

[{"type":"text","content":"CAMBRIDGE, Mass., March 30, 2021 /PRNewswire/ -- Invaio Sciences, Inc., a Flagship Pioneering company focused on unlocking the potential of the planet's interdependent natural systems to solve pressing agriculture, nutrition and environmental challenges, announced today the appointment of Peleg Chevion as President and Chief Commercial Officer. Chevion, who joined the company in late 2020, will focus on accelerating the commercial activities of the company.\n\n \n \n \n \n \n \n\n \n\"Our goal at Invaio is to accelerate the transition in agriculture from a chemical-based industry to a biological-based industry that addresses the needs of farmers and society, while protecting the environment,\" said Ignacio Martinez, Co-Founder and CEO, Invaio. \"The company is now transitioning from an R&D-focused organization to a full commercial enterprise.\"\nMartinez continued, \"Peleg has already made a significant impact at Invaio since he joined the company in late 2020. He brings a very unique set of experiences, commercial leadership, and an entrepreneurial mindset perfectly suited for the next phase of the company.\"\nPrior to joining Invaio, Chevion was President and Chief Commercial Officer of Blendhub, a global leader in food and ingredients production. Before Blendhub, Peleg worked with Lindsey Goldberg, a leading global private equity firm based in New York. Chevion also worked for seven years as a senior executive at Syngenta where he started and then led the Abiotic Stress Management indication across the spectrum of chemical, biological, genetics and digital platforms. Prior to Syngenta, Chevion spent several years leading Business Development at Crucell before the company was acquired by J&J.\nChevion began his career as an officer in the Israeli Air Force, and later held diverse roles in the Israeli startup ecosystem. Chevion graduated from the IDF Computer Academy. He received an L.L.B from Tel Aviv University, an MBA from INSEAD and is a licensed attorney in Israel.\n\"Since joining Invaio last year, I have been impressed by the breakthrough platform technologies we are developing, our integrated solutions approach and the commercial traction of the company,\" said Peleg Chevion, President and Chief Commercial Officer, Invaio. \"We are curing diseases like Greening in Citrus and Xylella in Olives, significantly reducing the...

More updates from Denali Therapeutics Inc.